Sagar Lonial Discusses Treating Patients With Myeloma

SAGAR LONIAL, MD
Wednesday, December 23, 2015
Talk about this article with nurses and others in the oncology community in the General Discussions Oncology Nursing News discussion group.


Sagar Lonial, MD, chief medical officer, Winship Cancer Institute of Emory University and Professor and Executive Vice Chair, Department of Hematology and Medical Oncology, Emory University School of Medicine, discusses treating patients with myeloma.

Lonial says that care should be directed by a myeloma expert who can define a treatment plan over the next 6 to 12 months.

While new treatment options for myeloma have recently emerged, Lonial says it’s important for providers to know when to treat and when not treat with a new drug. He adds that patients should be encouraged to admit any adverse events, particularly neuropathy or fatigue, which can impact quality of life.



Talk about this article with nurses and others in the oncology community in the General Discussions Oncology Nursing News discussion group.
External Resources

MJH Associates
American Journal of Managed Care
Cure
MD Magazine
Pharmacy Times
Physicians' Education Resource
Specialty Pharmacy Times
TargetedOnc
OncNurse Resources

Blogs
Continuing Education
Discussions
Web Exclusives


About Us
Advertise
Advisory Board
Careers
Contact Us
Privacy Policy
Terms & Conditions
Intellisphere, LLC
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 609-716-7777
F: 609-716-4747

Copyright OncNursing 2006-2017
Intellisphere, LLC. All Rights Reserved.